pyridostigmine bromide has been researched along with Autosomal Dominant Myotubular Myopathy in 5 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 5 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Elahi, B; Laughlin, RS; Liewluck, T; Litchy, WJ; Milone, M | 1 |
| Liu, YT; Luo, HY; Mao, CY; Niu, HX; Shi, CH; Wang, YL; Xu, YM; Yang, J; Yang, ZH; Zhao, L | 1 |
| Abbs, S; Beeson, D; Cullup, T; Dowling, JJ; Feng, L; Jungbluth, H; Knight, RK; Kress, W; Laporte, J; Lees, MM; Lillis, S; Manzur, AY; Mills, KR; Muntoni, F; Pike, MG; Pitt, MC; Robb, SA; Sewry, CA | 1 |
| Beggs, AH; Buj-Bello, A; Dowling, JJ; Dulin-Smith, AN; Durban, AN; Joubert, R; Li, X; Low, SE; Marshall, JT; Marshall, ML; Messaddeq, N; Pierson, CR; Snyder, AD | 1 |
| Clarke, NF; Dowling, JJ; Feldman, EL; Gibbs, EM; Oates, EC; Rose, K; Webster, R | 1 |
5 other study(ies) available for pyridostigmine bromide and Autosomal Dominant Myotubular Myopathy
| Article | Year |
|---|---|
Neuromuscular transmission defects in myopathies: Rare but worth searching for.
Topics: Cholinesterase Inhibitors; Cohort Studies; Electrodiagnosis; Electromyography; Female; Genetic Diseases, X-Linked; Humans; Hydroxychloroquine; Immunotherapy; Lysosomal Storage Diseases; Male; Motor Neurons; Muscle, Skeletal; Muscular Diseases; Myopathies, Structural, Congenital; Pyridostigmine Bromide; Synaptic Transmission | 2019 |
Novel compound heterozygous GFPT1 mutations in a family with limb-girdle myasthenia with tubular aggregates.
Topics: Action Potentials; Animals; Asian People; Cholinesterase Inhibitors; Databases, Genetic; Electric Stimulation; Female; Genetic Testing; Glutamine-Fructose-6-Phosphate Transaminase (Isomerizing); Humans; Male; Muscle, Skeletal; Muscular Dystrophies, Limb-Girdle; Mutation, Missense; Myopathies, Structural, Congenital; Pedigree; Polymorphism, Single Nucleotide; Pyridostigmine Bromide; Young Adult | 2019 |
Impaired neuromuscular transmission and response to acetylcholinesterase inhibitors in centronuclear myopathies.
Topics: Adolescent; Animals; Biopsy; Child; Cholinesterase Inhibitors; Disease Models, Animal; Electromyography; Female; Gene Knockout Techniques; Humans; Infant; Male; Muscle, Skeletal; Myopathies, Structural, Congenital; Neuromuscular Junction; Protein Tyrosine Phosphatases, Non-Receptor; Pyridostigmine Bromide; Synaptic Transmission; Treatment Outcome; Zebrafish; Zebrafish Proteins | 2011 |
Myotubular myopathy and the neuromuscular junction: a novel therapeutic approach from mouse models.
Topics: Animals; Cell Membrane; Disease Models, Animal; Gene Expression Regulation; Mice; Mice, Knockout; Motor Activity; Myopathies, Structural, Congenital; Neuregulin-1; Neuromuscular Junction; Phenotype; Pyridostigmine Bromide; Receptors, Cholinergic; Signal Transduction; Synaptic Transmission | 2012 |
Neuromuscular junction abnormalities in DNM2-related centronuclear myopathy.
Topics: Adult; Animals; Child; Cholinesterase Inhibitors; Disease Models, Animal; Dynamin II; Female; Humans; Male; Motor Activity; Muscle Weakness; Muscle, Skeletal; Myopathies, Structural, Congenital; Neuromuscular Junction; Pyridostigmine Bromide; Young Adult; Zebrafish | 2013 |